Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Sat Nusapersada Tbk (PTSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Sat Nusapersada Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Sat Nusapersada Tbk trades at Rp286 (market cap 1.54T, 107.9K 24h volume). The key difference: Sat Nusapersada Tbk is far larger — about 4.9× Diagnos Laboratorium Utama Tbk.'s market cap, and Sat Nusapersada Tbk is more actively traded (107.9K versus 41.7K). Which is the better fit depends on your goals.
| DGNS | PTSN | |
|---|---|---|
Market Cap | 316.25B | 1.54T |
Volume | 41.7K | 107.9K |
Lot | 417 | 1.08K |
Turnover | 9.66M | 30.9M |
Average Price | 231.65 | 286.41 |
Value | 9.66M | 30.9M |
Indicative Equilibrium Price | 230 | 286 |
Indicative Equilibrium Volume | 2.4K | 4 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Sat Nusapersada Tbk
Sat Nusapersada Tbk (the company) was established on Jun 1, 1990 based on Notaries Deed No. 5 and the deed of establishment was approved by the the Ministry of Justice dated Sept 18, 1991. The Company’s articles of association has been amended several times, most recently by notarial deed No. 14 of Fathiah Helmi, S.H., dated Aug 7, 2007, concerning public offering.
Read more on PTSN →
